Psychedelics as Psychiatric Medications
-10%
portes grátis
Psychedelics as Psychiatric Medications
Castle, David; Nutt, David
Oxford University Press
03/2023
160
Mole
Inglês
9780192863607
15 a 20 dias
Descrição não disponível.
Ishrat Husain and Chase Thompson: 1. Historical Overview
Laurie Highbed and Ben Sessa: 2. The psychotherapeutic component of psychedelic medicine (includes set, setting, anticipation, expectancy, preparation, integration)
David Erritzoe and James Rucker: 3. Psilocybin
Michael Mithoefer and David Presti: 4. MDMA
Mihai Avram, Felix Mueller and Stefan Borgwardt: 5. Lysergic Acid Diethylamid: In Search of the Wonder Drug
Daniel Perkins, Simon Ruffell, and Jerome Sarris: 6. Ayahuasca
Deborah Mash: 7. Ibogaine
James Linden and Daniel Robin: 8. Other psychedelics
Joshua Di Vincenzo, Joshua Rosenblat and Roger McIntyre: 9. Ketamine
Jo Neil, Mohammed Shahid, Rosalind Gittins, Anne K Schalg and Frank I Tarazi: 10. Risks and side effects associated with the use of psychedelics
David Castle, David Nutt and Nicole Ledwos: 11. Psychedelics as psychiatric medicines: current challenges and future prospects
Laurie Highbed and Ben Sessa: 2. The psychotherapeutic component of psychedelic medicine (includes set, setting, anticipation, expectancy, preparation, integration)
David Erritzoe and James Rucker: 3. Psilocybin
Michael Mithoefer and David Presti: 4. MDMA
Mihai Avram, Felix Mueller and Stefan Borgwardt: 5. Lysergic Acid Diethylamid: In Search of the Wonder Drug
Daniel Perkins, Simon Ruffell, and Jerome Sarris: 6. Ayahuasca
Deborah Mash: 7. Ibogaine
James Linden and Daniel Robin: 8. Other psychedelics
Joshua Di Vincenzo, Joshua Rosenblat and Roger McIntyre: 9. Ketamine
Jo Neil, Mohammed Shahid, Rosalind Gittins, Anne K Schalg and Frank I Tarazi: 10. Risks and side effects associated with the use of psychedelics
David Castle, David Nutt and Nicole Ledwos: 11. Psychedelics as psychiatric medicines: current challenges and future prospects
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Ishrat Husain and Chase Thompson: 1. Historical Overview
Laurie Highbed and Ben Sessa: 2. The psychotherapeutic component of psychedelic medicine (includes set, setting, anticipation, expectancy, preparation, integration)
David Erritzoe and James Rucker: 3. Psilocybin
Michael Mithoefer and David Presti: 4. MDMA
Mihai Avram, Felix Mueller and Stefan Borgwardt: 5. Lysergic Acid Diethylamid: In Search of the Wonder Drug
Daniel Perkins, Simon Ruffell, and Jerome Sarris: 6. Ayahuasca
Deborah Mash: 7. Ibogaine
James Linden and Daniel Robin: 8. Other psychedelics
Joshua Di Vincenzo, Joshua Rosenblat and Roger McIntyre: 9. Ketamine
Jo Neil, Mohammed Shahid, Rosalind Gittins, Anne K Schalg and Frank I Tarazi: 10. Risks and side effects associated with the use of psychedelics
David Castle, David Nutt and Nicole Ledwos: 11. Psychedelics as psychiatric medicines: current challenges and future prospects
Laurie Highbed and Ben Sessa: 2. The psychotherapeutic component of psychedelic medicine (includes set, setting, anticipation, expectancy, preparation, integration)
David Erritzoe and James Rucker: 3. Psilocybin
Michael Mithoefer and David Presti: 4. MDMA
Mihai Avram, Felix Mueller and Stefan Borgwardt: 5. Lysergic Acid Diethylamid: In Search of the Wonder Drug
Daniel Perkins, Simon Ruffell, and Jerome Sarris: 6. Ayahuasca
Deborah Mash: 7. Ibogaine
James Linden and Daniel Robin: 8. Other psychedelics
Joshua Di Vincenzo, Joshua Rosenblat and Roger McIntyre: 9. Ketamine
Jo Neil, Mohammed Shahid, Rosalind Gittins, Anne K Schalg and Frank I Tarazi: 10. Risks and side effects associated with the use of psychedelics
David Castle, David Nutt and Nicole Ledwos: 11. Psychedelics as psychiatric medicines: current challenges and future prospects
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
